Lenalidomide SPC

Lenalidomide SPC is indicated for the treatment of:

Multiple myeloma (MM).

Myelodysplastic syndrome (MDS).

Mantle cell lymphoma (MCL).

Strength:

2.5 mg

5 mg

10 mg

15 mg

20 mg

25 mg

Dosage Form:

Capsule.

Active ingredient:

Lenalidomide.

Pomalidomide SPC

Pomalidomide SPC is indicated for the treatment of Multiple myeloma (MM).

Strength:

1 mg

2 mg

3 mg

4 mg

Dosage Form:

Capsule

Active ingredient:

Pomalidomide.

Bortezomib SPC

Bortezomib SPC is indicated for the treatment of:

Multiple myeloma (MM).

Mantle cell lymphoma (MCL).

Strength:

3.5 mg

Dosage Form:

Vial for injection.

Active ingredient:

Bortezomib.

Carfilzomib SPC

Carfilzomib SPC is indicated for the treatment of Multiple myeloma (MM).

Strength:

60 mg

Dosage Form:

Vial for injection.

Active ingredient:

Carfilzomib.